US 9782399
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
granted A61KA61K31/165A61K31/167
Quick answer
US patent 9782399 (Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/165, A61K31/167, A61K31/192, A61K31/195